PerkinElmer, Inc. - All News Releases

PERKINELMER LAUNCHES NEW ONESOURCE® LABORATORY CONSULTING SERVICES TO DRIVE IMPROVED LABORATORY EFFICIENCIES

Thu, 16 May 2013 04:00:00 GMT

WALTHAM, Mass. – May 16, 2013 –PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it is expanding its OneSource® Laboratory Services offering to include strategic laboratory consulting services. OneSource® Strategic Lab Solutions will deliver the combined power of PerkinElmer's expertise in informatics, instrumentation, service and process optimization, to increase laboratories' productivity and performance.

Due to limited access to laboratory personnel, information technology expertise and budgetary resources, it is often challenging for companies to focus on optimizing their laboratory o...

Top Health Insurance Plans Expanded Coverage of the Verifi® Non-Invasive Prenatal Test to Detect Down Syndrome & Other Chromosomal Abnormalities

Tue, 14 May 2013 12:00:00 GMT

Coverage increases access to over 80 million covered lives WALTHAM, Mass. & REDWOOD CITY, Calif.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader in maternal and fetal health, and Verinata Health, an Illumina company and innovator of non-invasive prenatal tests (NIPT), today announced that several of the top health insurance plans have expanded coverage of the verifi® prenatal test for a variety of potential fetal health risks to over 80 million covered lives. The verifi® test is among the recently covered DNA-based NIPTs that detect multiple fetal chromosomal an...

PerkinElmer to Present at UBS Global Healthcare Conference

Mon, 13 May 2013 20:05:00 GMT

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today announced that the Company will present at the UBS Global Healthcare Conference on Monday, May 20, 2013, at 4:00 pm Eastern Time at the Sheraton New York Hotel and Towers in New York City. Robert F. Friel, PerkinElmer's chairman and chief executive officer, will provide an overview of the Company and its strategic objectives. A live audio webcast of this presentation will also be available on the Investor section...

CASE STUDY: PerkinElmer Chromatography Techniques Used to Verify Dairy Authenticity and Adulteration

Mon, 13 May 2013 04:00:00 GMT

Summary:
Disguising Conventional Milk as Organic - With the rise in popularity of organic milk and the higher price that organic milk can demand, it is important for dairy processors to protect their investments and verify the authenticity of the milk powders and conventional milks they are sourcing from producers. To be considered organic, milk must adhere to strict rules governing dairy cow grazing conditions and comply with the requirements for the absence of any pesticides, antibiotic residues and bovine growth hormone (BGH) traces. Although these factors can be difficult to trace, analytical testing technologies are enabling dairy processo...

PerkinElmer Embarks with Blaze Bioscience on Innovative Translational Imaging Application to Significantly Improve Intraoperative Detection of Tumors

Wed, 08 May 2013 04:00:00 GMT

Summary: PerkinElmer is working in collaboration with Blaze Bioscience to provide real-time near-infrared fluorescence imaging of tumors for surgical oncology research applications with the ultimate goal of translating these disruptive solutions into the clinic.

As part of its objective to translate cutting-edge research technologies into clinical innovations, a PerkinElmer fluorescence imaging system is being used with Blaze Bioscience's Tumor Paint™ technology in surgical-guidance applications intended to significantly improve surgical oncology outcomes for multiple tumor types in canine patients. The study is being conducted at Washington State University's (WSU) Vete...

PerkinElmer Introduces New Chemical Intelligence Capabilities for Accelerating the Lead Discovery Process

Wed, 08 May 2013 04:00:00 GMT

NEWTON, Mass. – May 8, 2013 – PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, is introducing the newest version of Lead Discovery for the TIBCO Spotfire® software platform at the Company's Revolutionaries for Global Health Summit. The new functionality of Lead Discovery 5.1 combined with the TIBCO Spotfire® software's advanced data visualization and analysis capabilities bring a new level of chemical intelligence to the informatics platform for advanced scientific discovery.

PerkinElmer's Lead Discovery™ 5.1 enhances the TIBCO Spotfire® software data analysis capabilities with new functionality bui...

ViaCord® to Advance Cord Blood Stem Cell Therapy Research through Collaboration with the Center for International Blood and Marrow Transplant Research®

Tue, 30 Apr 2013 04:00:00 GMT

WALTHAM, Mass. – April 30, 2013 –ViaCord, PerkinElmer's family cord blood and tissue preservation business, is collaborating with the Center for International Blood and Marrow Transplant Research (CIBMTR) to collect, maintain and publish research from ViaCord's cord blood stem cell transplants. This collaboration will expand knowledge of cord blood-derived stem cell applications throughout the medical and research community. To date, CIBMTR's large network of transplant centers has resulted in the development of a clinical database of more than 30,000 cord blood transplant recipients for clinical decision-making, use in studies, and other research purposes with the goal of making...

PerkinElmer to Host Revolutionaries for Global Health Summit in Newton, MA

Mon, 29 Apr 2013 04:00:00 GMT

Newton, MA – April 29, 2013 - PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, is hosting a Revolutionaries for Global Health Summit from Wednesday May 8th through Thursday May 9th 2013 at the Boston Marriot Newton Hotel. The Summit is a forum for leading researchers and physicians to network and share best practices in both science and business and participate in cutting-edge discussions to help lead to better prevention, detection and treatment of disease. The meeting program will feature world-renowned experts presenting key insights on finding, understanding, and acting upon the causes and effects of disease including cancer, diabet...

PerkinElmer Announces Financial Results for the First Quarter of 2013

Thu, 25 Apr 2013 20:21:00 GMT

Revenue decline of 1%; Organic revenue declined 1% GAAP earnings per share from continuing operations of $0.28; Adjusted earnings per share of $0.36 Reduces GAAP earnings per share guidance to $1.30 to $1.40; Adjusted earnings per share guidance to $2.00 to $2.10 WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the first quarter ended March 31, 2013. The Company repor...

PerkinElmer to Hold Earnings Call on Thursday, April 25, 2013

Tue, 09 Apr 2013 20:05:00 GMT

WALTHAM, Mass.--(BUSINESS WIRE)-- PerkinElmer, Inc., (NYSE:PKI) a global leader focused on improving the health and safety of people and the environment, today announced that on Thursday, April 25, 2013, after market close, the Company will release first quarter 2013 results. The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert F. Friel, chairman and chief executive officer, and Andy Wilson, senior vice president and chief financial officer will host the conference call. To access the call, please dial (617) 399-5129 prior to the scheduled ...